Cubist Systematic Strategies, LLC Genetron Holdings LTD Transaction History

Cubist Systematic Strategies, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.87 - $1.04 $6,427 - $7,683	-7,388 Reduced 34.17%	14,233 $13,000
Q1 2023 May 15, 2023	SELL	$0.91 - $1.23 $1,560 - $2,109	-1,715 Reduced 7.35%	21,621 $22,000
Q4 2022 Feb 14, 2023	BUY	$0.8 - $1.12 $18,668 - $26,136	23,336 New	23,336 $26,000
Q2 2022 Aug 15, 2022	SELL	$1.28 - $2.4 $11,936 - $22,380	-9,325 Reduced 43.55%	12,089 $21,000
Q1 2022 May 16, 2022	SELL	$2.19 - $6.09 $56,173 - $156,208	-25,650 Reduced 54.5%	21,414 $47,000
Q4 2021 Feb 14, 2022	BUY	$5.81 - $14.39 $273,441 - $677,250	47,064 New	47,064 $287,000
Q3 2021 Nov 15, 2021	SELL	$11.55 - $20.3 $196,835 - $345,952	-17,042 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$17.9 - $23.29 $272,527 - $354,590	-15,225 Reduced 47.18%	17,042 $343,000
Q1 2021 May 17, 2021	BUY	$13.71 - $30.64 $230,753 - $515,701	16,831 Added 109.04%	32,267 $692,000
Q4 2020 Feb 16, 2021	BUY	$9.31 - $14.0 $142,880 - $214,858	15,347 Added 17243.82%	15,436 $216,000
Q3 2020 Nov 16, 2020	BUY	$9.1 - $15.81 $809 - $1,407	89 New	89 $1,000

7.5K

Ticker GTH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 90,602,304
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.